4928.T
4928.T
JP3760450001
NOEVIR HLDGS CO LTD
Loading chart...

Company Profile

Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, toiletries, medical supplies, and food products in China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, and Canada. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; excel make up line products and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical and food business segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparel, body fashion, aircraft and ships, air transportation and pilot training business, etc. The company also provides market research. The company sells its products through drug stores and variety stores, and dermatology and medical institutions, as well as Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Kobe, Japan.

Related stocks

4919.T
4919.T • Japan
MILBON CO LTD
3,315 JPY
660.73M USD 1Y +35.9%
4985.T
4985.T • Japan
EARTH CORPORATION
4,700 JPY
651.01M USD 1Y -9.1%
7956.T
7956.T • Japan
PIGEON CORP
2,099 JPY
1.58B USD 1Y +18.8%
4922.T
4922.T • Japan
KOSE HLDGS CORP
5,514 JPY
1.98B USD 1Y -5.5%
4927.T
4927.T • Japan
POLA ORBIS HOLDINGS INC
1,380.5 JPY
1.93B USD 1Y +4%
605009.SS
605009.SS • China
HANGZHOU HAOYUE PERSONAL CARE C
25.89 CNY
832.75M USD 1Y -19.8%
2145.HK
2145.HK • China
CHICMAX
21.94 HKD
1.1B USD 1Y -75.9%
4967.T
4967.T • Japan
KOBAYASHI PHARMACEUTICALS
7,238 JPY
3.4B USD 1Y +37.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

5/7 Elevated
5Y Volatility
17.0% p.a.
Max Drawdown (5Y)
-33.3%
Sharpe Ratio (5Y)
-0.36
Beta Factor
0.15
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Historical Stress Test: Maximum peak-to-trough drawdown of -56.0% in the extended horizon.
ende